BRIEF-Vital Therapies provides corporate update
September 13, 2016 at 16:05 PM EDT
* Formed commercialization committee to formulate commercial strategy in anticipation of positive outcome for VTL-308 phase 3 clinical trial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.